# Clinical trials recruiting in Germany: 3,153 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 3,153 trials recruiting or not yet recruiting with a site in Germany, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Germany: 3,153 rows for $111.53, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 56 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/germany

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 3,153
- Recruiting or not yet: 3,153
- Read on: November 19, 2026

## Trials

The 25 newest of 3,153, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947095 | Investigating the Effectiveness of Calisda, a Digital Health Intervention for Patients With Menopause Symptoms | Gaia AG | Not applicable | Not yet recruiting | Menopause Symptoms | 388 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947095) |
| November 18, 2026 | NCT07946731 | Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA - Part B | University of Ulm | Observational | Not yet recruiting | Gestatiaonl Diabetes Mellitus | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946731) |
| November 18, 2026 | NCT07946367 | Dual-targeting of B & T Cell Pathways Evaluation Trial | Diabetes Free, Inc. | Phase 1/2 | Recruiting | Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Idiopathic Inflammatory... | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946367) |
| November 18, 2026 | NCT07944326 | Cardiovascular and Renal Protection With SGLT Inhibition in Kidney Transplant Recipients: The RENAISSANCE Trial | University of British Columbia | Phase 3 | Not yet recruiting | Kidney Transplant Recipient | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944326) |
| November 17, 2026 | NCT07943325 | Delayed Application of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer | Goethe University | Phase 3 | Not yet recruiting | Advanced NSCLC, Metastatic NSCLC - Non-Small Cell Lung Cancer | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943325) |
| November 16, 2026 | NCT07940244 | A Study to Compare How Survodutide is Taken up by the Body When Given in 2 Formulations to People With Overweight or Obesity | Boehringer Ingelheim | Phase 1 | Not yet recruiting | Healthy, Obesity | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940244) |
| November 16, 2026 | NCT07940023 | Bispecific PSMAxCD3 Antibody CC-1 Applied Subcutaneously in Patients With Castration Resistant Prostate Carcinoma | University Hospital Tuebingen | Phase 1 | Not yet recruiting | Castration Resistant Prostate Cancer, Prostate Cancer | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940023) |
| November 16, 2026 | NCT07939334 | Effects of a Botanical Extract on Cognitive Performance and Cerebral Blood Flow in Healthy Adults | Finzelberg GmbH & Co. KG | Not applicable | Not yet recruiting | Cognitive Change, Cerebral Blood Flow, Memory, Stress (Psychology) | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939334) |
| November 16, 2026 | NCT07939139 | Shadow-Mode Evaluation of an AI Assistant for Multidisciplinary Tumor Boards | Technical University of Munich | Observational | Recruiting | Hematologic Neoplasms, Sarcoma, Bone Neoplasms, Head and Neck Neoplasms | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939139) |
| November 16, 2026 | NCT07938788 | Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism | University of Kiel | Not applicable | Not yet recruiting | Healthy, Overweight (BMI \> 25) | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938788) |
| November 13, 2026 | NCT07937215 | Silica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot Wounds | Cutempa Medical AG | Not applicable | Recruiting | Diabetic Foot Disease, Foot Ulcer Due to Type 1 Diabetes Mellitus, Foot Ulcer Due to Type 2 Diabetes Mellitus | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937215) |
| November 13, 2026 | NCT07936786 | HIIT-based Exercise Intervention for Improvement of Immunomodulatory, Cardiopulmonary, and Psychosocial Parameters During Maintenance... | University of Erlangen-Nürnberg Medical School | Not applicable | Not yet recruiting | Leukemia, HIIT, Sport | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936786) |
| November 13, 2026 | NCT07936552 | Blood Flow Restriction Training After TIPS Placement in Liver Cirrhosis | German Diabetes Center | Not applicable | Not yet recruiting | Liver Cirrhosis, TIPS Insertion | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936552) |
| November 13, 2026 | NCT07934654 | The LITTLE OWLS Study (in German: "Kleine Eulen OWL"): Exploring the Early-life Microbiome Development and Physical and Mental Health... | Bielefeld University | Observational | Recruiting | Dermatitis, Atopic Dermatitis, Asthma (Diagnosis), Eczema, Allergy, Overweight , Obesity, Inflamatory Bowel Disease... | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934654) |
| November 12, 2026 | NCT07933198 | Gut Microbial Metabolites and Intestinal Permeability in Patients With Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid... | Heart and Diabetes Center North-Rhine Westfalia | Not applicable | Recruiting | Tricuspid Valve Regurgitation | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933198) |
| November 12, 2026 | NCT07933172 | Exercise Metrics and Perfusion Indices in CoRonary Microvascular Dysfunction: A Multimodal Correlative Study in ANOCA and HFpEF Patients... | Heart and Diabetes Center North-Rhine Westfalia | Not applicable | Recruiting | CMD, Microvascular Dysfunction, Anoca, Hfpef | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933172) |
| November 12, 2026 | NCT07932795 | Study of Multiple Ascending Doses (MAD) of M5542 in Participants With Moderate and Severe Eczema | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Not yet recruiting | Eczema | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932795) |
| November 12, 2026 | NCT07932262 | An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1 | University Hospital Tuebingen | Phase 1/2 | Not yet recruiting | Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV), Rheumatoid Arthritis (RA), IIM, Multiple Sclerosis, Immune... | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932262) |
| November 12, 2026 | NCT07932093 | Unveiling Maternal-fetal BRAin-body Interactions in Pregnant WOmen Affected by Depression | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Not applicable | Recruiting | Depression in Pregnancy, Major Depressive Disorder, Pregnancy | 720 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932093) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 12, 2026 | NCT07931235 | Breath Acetone During Tirzepatide Treatment and Resistance Training in Adults With Obesity | Technical University of Munich | Observational | Not yet recruiting | Obesity (Disorder) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931235) |
| November 12, 2026 | NCT07930559 | Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue Contusions | Aponia Laboratories, Inc. | Phase 3 | Recruiting | Acute Pain Due to Trauma | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930559) |
| November 10, 2026 | NCT07929051 | A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With Obrixtamig | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Advanced Cancer | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929051) |
| November 9, 2026 | NCT07926932 | Whole-Body Electromyostimulation and Speed Climbing | University of Erlangen-Nürnberg Medical School | Not applicable | Not yet recruiting | Athletic Performance | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926932) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Charité - Universitätsmedizin Berlin | Berlin | 82 |
| University Medical Center Hamburg-Eppendorf | Hamburg | 66 |
| Universitätsklinikum Essen | Essen | 56 |
| Universitätsklinikum Leipzig | Leipzig | 54 |
| Universitätsklinikum Hamburg-Eppendorf | Hamburg | 53 |
| Universitätsklinikum Ulm | Ulm | 51 |
| Universitätsklinikum Tübingen | Tübingen | 50 |
| Universitätsklinikum Jena | Jena | 49 |
| Universitätsklinikum Münster | Münster | 49 |
| Universitaetsklinikum Ulm | Ulm | 49 |
| Universitaetsklinikum Essen | Essen | 48 |
| Universitätsklinikum Freiburg | Bad Krozingen | 47 |
| Universitätsklinikum Erlangen | Erlangen | 47 |
| Universitätsklinikum Frankfurt | Frankfurt | 45 |
| Universitätsklinikum Würzburg | Würzburg | 44 |
| Universitätsklinikum Bonn | Bonn | 42 |
| Universitätsklinikum Heidelberg | Heidelberg | 42 |
| Universitätsklinikum Düsseldorf | Düsseldorf | 35 |
| Klinikum Chemnitz gGmbH | Chemnitz | 35 |
| Universitätsklinikum Schleswig-Holstein | Lübeck | 34 |
| Charité Universitätsmedizin Berlin | Berlin | 34 |
| University Hospital Essen | Essen | 33 |
| Universitaetsklinikum Heidelberg | Heidelberg | 32 |
| University Hospital Bonn | Bonn | 31 |
| Universitätsklinikum Augsburg | Augsburg | 29 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 5 |
| Phase 1 | 119 |
| Phase 1/2 | 154 |
| Phase 2 | 327 |
| Phase 2/3 | 67 |
| Phase 3 | 616 |
| Phase 4 | 61 |
| Not applicable | 714 |
| Observational | 1,090 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 93 |
| Breast Neoplasms | 93 |
| Heart Failure | 81 |
| Neoplasms | 79 |
| Obesity | 70 |
| Colorectal Neoplasms | 59 |
| Prostatic Neoplasms | 56 |
| Atrial Fibrillation | 49 |
| Multiple Myeloma | 45 |
| Lung Neoplasms | 44 |
| Neoplasm Metastasis | 44 |
| Diabetes Mellitus, Type 2 | 42 |
| Stroke | 39 |
| Recurrence | 38 |
| Overweight | 38 |
| Parkinson Disease | 36 |
| Cardiovascular Diseases | 35 |
| Ischemic Stroke | 35 |
| Melanoma | 32 |
| Coronary Artery Disease | 32 |
| Squamous Cell Carcinoma of Head and Neck | 32 |
| Ovarian Neoplasms | 32 |
| Motor Activity | 31 |
| Pulmonary Disease, Chronic Obstructive | 29 |
| Depression | 29 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 93 |
| Charite University, Berlin, Germany | 82 |
| University Hospital Tuebingen | 74 |
| Universitätsklinikum Hamburg-Eppendorf | 63 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 55 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 51 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 49 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 42 |
| University Hospital Heidelberg | 42 |
| Heinrich-Heine University, Duesseldorf | 42 |
| University of Erlangen-Nürnberg Medical School | 41 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 40 |
| Technical University of Munich | 40 |
| Technische Universität Dresden | 38 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 36 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 32 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 30 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 28 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 27 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 24 |
| University of Ulm | 24 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 23 |
| University Hospital, Bonn | 21 |
| University Hospital, Essen | 21 |
| University Hospital Schleswig-Holstein | 20 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Escrow companies in the United States](https://specstream.ai/data/businesses/escrow-companies/united-states)
- [Document shredding companies in the United States](https://specstream.ai/data/businesses/document-shredding-companies/united-states)
- [Community health centers in the United States](https://specstream.ai/data/businesses/community-health-centers/united-states)
- [Cafeterias in the United States](https://specstream.ai/data/businesses/cafeterias/united-states)
- [Bar and grill restaurants in the United States](https://specstream.ai/data/businesses/bar-and-grill-restaurants/united-states)
- [Automotive companies in the United States](https://specstream.ai/data/businesses/automotive-companies/united-states)
